What is VaxPro?
VaxPro specializes in delivering comprehensive on-site vaccination solutions, encompassing services such as flu vaccinations, COVID-19 vaccinations, tuberculosis testing, and biometric screenings. The company caters to a broad clientele, including corporate entities, educational institutions, senior living communities, healthcare providers, and public events across the United States. Leveraging over 25 years of operational experience, VaxPro is recognized for its efficient, insured, and HIPAA-compliant service delivery, prioritizing both client convenience and public health objectives. Their core mission revolves around simplifying health management for organizations by providing year-round support and facilitating access to crucial personal health insights.
How much funding has VaxPro raised?
VaxPro has raised a total of $38K across 1 funding round:
Debt
$38K
Debt (2021): $38K with participation from PPP
Key Investors in VaxPro
PPP
Public-Private Partnership
What's next for VaxPro?
With the recent infusion of substantial expansion capital, VaxPro is poised for accelerated growth and strategic market expansion. The company is likely to invest in enhancing its service infrastructure, potentially broadening its geographical reach, and deepening its technological capabilities to further streamline its on-site vaccination and health screening services. This strategic financing will enable VaxPro to solidify its market leadership and respond effectively to the increasing demand for accessible and convenient public health solutions, particularly within corporate and community settings. The company's focus will remain on maintaining its high standards of service efficiency, compliance, and client satisfaction as it scales.
See full VaxPro company page
